This is an analysis completed by The Dividend Guy. It is not to be used as investment advice or a recommendation to buy, hold, or sell any stocks discussed. Please ensure you complete your own analysis.
As a holder of Pfizer, I am not in the market for another pharmaceutical company. However, with the […]
I have owned Wal-Mart as a dividend growth stock since June 23, 2006. This stock has continued to increase its dividend year after year at a nice rate. My effective dividend yield is higher than the current yield on the stock, which is really what dividend investors are looking for.
As a reminder, I […]
He says it throughout his annual report. In the section titled, Fanciful Figures – How Public Companies Juice Earnings he talks at great depth about the low likelihood that we are going to see the same gains we saw in the 20th century. He states a 5.3% compound return for the period. […]
Pfizer has been one of those stocks that continues to increase its dividend year after year, yet the stock price does not respond. There is a lot of uncertainty around the product pipeline and the expiry of key patents. However, the stock continues to increase its dividends and as we know from research, […]